Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous aminophylline for recovery after upper gastrointestinal endoscopy
IRCT20121216011766N8Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aminophylline (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Eye opening time, Recovery time and 4 more. Started Aug 2025; status: completed.
02
Drugs
aminophylline
Beyond the preview
Go deeper on IRCT20121216011766N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121216011766N8.